Executive Training for drug policy managers
At the initiative of the Polish Presidency of the Pompidou Group, a new training offering support in drug policy management was launched in 2010. The main objective is to facilitate know-how and build capacities for more effective policy implementation, management and evaluation.
The first pilot training course was co-organised with the Polish National Office of Drug Prevention and took place in Warsaw in May 2010 where some 30 managers from governmental institutions responsible for developing and implementing drug policies or coordinating programme implementation and service delivery were trained. Following its success, the training initiative was to be continued and further developed under the Work programme 2011-2014.
Training outline 2010
Training outline 2011
Training outline 2012
Regional assistance programme in Eastern Europe and Bosnia and Herzegovina on “Drugs in Prisons”
An integrated approach in dealing with the drug problem in Eastern Europe and Bosnia and Herzegovina will not only tackle supply reduction but also take measures in reducing drug demand in prisons. The supply of illicit drugs in prisons, high drug demand and lack of coverage of health services accounts for prisons being a priority area for preventing drug use. The main objective of the project “Preventing Drug Trafficking and Abuse in Prisons
- Extending best practices in Eastern Europe and Bosnia and Herzegovina” is to prevent drug trafficking and improve health in penitentiaries with respect for human rights. The project will further advance the development of strategies of social re-insertion of former drug using inmates in order to reduce recidivism and crime. The promotion of through-care shall sustain drug treatment effort and guarantee continuing care for people entering and leaving the prison.
Project outline for a regional conference
Preventing Drug Trafficking and Abuse in Prisons in the Republic of Moldova
Preventing Drug Trafficking and Abuse in Prisons in Romania (to come)
Preventing Drug Trafficking and Abuse in Prisons in Ukraine (to come)
Preventing Drug Trafficking and Abuse in Prisons in Bosnia and Herzegovina (to come)
Training and assistance in the framework of the Mediterranean network for co-operation on drugs and addictions (MedNET)
A series of training seminars on opiate substitution treatment, drug users care, conception, implementation and evaluation projects have taken place in Algeria, Morocco and Lebanon. Training also took place in the field of law enforcement in Algeria and Lebanon. More recently, projects have been carried out in Lebanon and Egypt on the evaluation of drug users needs in terms of treatment which will require further training for the medical staff. Regular training of the medical staff working in newly set up treatment
centres is also conducted with the introduction of University diplomas in addictology in Morocco. A similar diploma should also be proposed in 2012 in Tunisia.
More information on the Mediterranean Network (MedNET)
MedNET country by country co-operation report
Training course on qualitative drug research
The aim of this course which is financed by the Pompidou Group and co-organised with ESSD
(European Society for Social Drug Research) is to enable young researchers to expand their
knowledge and abilities concerning qualitative drug research and provide them with some proficiency
in communicating research finding to agencies and policy makers. The first two editions took place in Amsterdam in August 2008 and 2009.
Training of parents, educators and NGO representatives to prevention
In 2007-2008,the Pompidou Group organised five 5-days seminars on life skills methodology for over 150 representatives
of NGOs, educators and social workers in the City of Zaporozhye, Ukraine with the aim to adopt this approach
to the context of prevention work in the entire country. Similar programmes are planned for Bulgaria,
Georgia, Lithuania and Romania.
Egypt Round Table
Annual Precursors Meeting
2nd meeting of the Expert Group on “Possible adverse
effects and associated cost of drug control policies”